{"title":"Correlation between pulmonary to systemic flow ratio and N-terminal Pro-B-type natriuretic peptide level in children with atrial septal defect.","authors":"Li-Chin Liao, Yun-Yu Chen, Yun-Ching Fu, Hui-Chih Hung","doi":"10.3389/fcvm.2025.1522603","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Atrial septal defect (ASD) increases pulmonary to systemic flow ratio (<i>Q</i> <sub>p</sub>/<i>Q</i> <sub>s</sub>) which is an important determinant factor for treatment. N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels are correlated with volume overloading of the heart. This study aims to explore the relationship between <i>Q</i> <sub>p</sub>/<i>Q</i> <sub>s</sub> and NT-proBNP levels in children with ASD.</p><p><strong>Materials and methods: </strong>Between January 2010 and December 2023, 464 patients under 20 years old with ASD who underwent cardiac catheterization and received NT-proBNP test were enrolled retrospectively. Baseline characteristics such as sex, body weight, and age were recorded. <i>Q</i> <sub>p</sub>/<i>Q</i> <sub>s</sub> was measured during standardized right heart catheterization according to Fick principle.</p><p><strong>Results: </strong>A significant positive correlation existed between NT-proBNP and <i>Q</i> <sub>p</sub>/<i>Q</i> <sub>s</sub> (R = 0.507, <i>P</i> < 0.001), with an <i>R</i> <sup>2</sup> of 0.258. The linear regression model indicates that a one-unit (pg/ml) increase in NT-proBNP corresponded to a 0.003-unit increase in <i>Q</i> <sub>p</sub>/<i>Q</i> <sub>s</sub> (<i>P</i> < 0.001). Patients with a <i>Q</i> <sub>p</sub>/<i>Q</i> <sub>s</sub> ratio ≥ 2 had significantly higher NT-proBNP levels than those with a ratio <2 (<i>P</i> < 0.001).</p><p><strong>Conclustion: </strong>This study, the largest cohort to date, reveals the correlation between non-invasive NT-proBNP level and invasive <i>Q</i> <sub>p</sub>/<i>Q</i> <sub>s</sub> measurement in children with ASD.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1522603"},"PeriodicalIF":2.8000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11949988/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1522603","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Atrial septal defect (ASD) increases pulmonary to systemic flow ratio (Qp/Qs) which is an important determinant factor for treatment. N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels are correlated with volume overloading of the heart. This study aims to explore the relationship between Qp/Qs and NT-proBNP levels in children with ASD.
Materials and methods: Between January 2010 and December 2023, 464 patients under 20 years old with ASD who underwent cardiac catheterization and received NT-proBNP test were enrolled retrospectively. Baseline characteristics such as sex, body weight, and age were recorded. Qp/Qs was measured during standardized right heart catheterization according to Fick principle.
Results: A significant positive correlation existed between NT-proBNP and Qp/Qs (R = 0.507, P < 0.001), with an R2 of 0.258. The linear regression model indicates that a one-unit (pg/ml) increase in NT-proBNP corresponded to a 0.003-unit increase in Qp/Qs (P < 0.001). Patients with a Qp/Qs ratio ≥ 2 had significantly higher NT-proBNP levels than those with a ratio <2 (P < 0.001).
Conclustion: This study, the largest cohort to date, reveals the correlation between non-invasive NT-proBNP level and invasive Qp/Qs measurement in children with ASD.
期刊介绍:
Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers?
At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.